Corneal Indications:

Clinical Benefits:

Stops progression of epithelial defects: Biologic action of cryopreserved amniotic membrane aids in the re-epithelialization of the corneal surface
ProKera® eliminates or postpones the need for surgery: Easily inserted in the office without the use of sutures or glue
AmnioGraft® fills defects of any size or depth: Graft can be molded and stacked to fill a corneal defect of any size
Easy to use: Durable and easy to handle
Avoid allograft rejection: Unlike tectonic corneal grafts, AmnioGraft® and ProKera® have no viable cells which eliminates the potential for allograft rejection
Reduces patient pain: Inflammation is reduced which reduces patient pain & the need for extended postoperative pain medication
Better immediate cosmetic outcome: Reduced inflammation at the surgical site
Good long term cosmetic outcome: Reduced scarring at surgical site

Supporting Literature:

Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br. J. Ophthalmol. 2001 Dec;85(12):1455-63.
Gregory DG. The ophthalmologic management of acute Stevens-Johnson syndrome. Ocular Surface. 2008 Apr;6(2):87-95.
Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SCG. Temporary Sutureless Amniotic Membrane Patch for Acute Alkaline Burns. Arch Ophthalmol; 126(8):1059-66.